Salvatore Privitera J.D.
Net Worth

Last updated:

What is Salvatore Privitera J.D. net worth?

The estimated net worth of Mr. Salvatore Privitera J.D. is at least $13,544,130 as of 30 May 2024. He owns shares worth $3,666,795 as insider, has earned $2,338,935 from insider trading and has received compensation worth at least $7,538,400 in AtriCure, Inc..

What is the salary of Salvatore Privitera J.D.?

Mr. Salvatore Privitera J.D. salary is $471,150 per year as Chief Technical Officer in AtriCure, Inc..

How old is Salvatore Privitera J.D.?

Mr. Salvatore Privitera J.D. is 58 years old, born in 1967.

What stocks does Salvatore Privitera J.D. currently own?

As insider, Mr. Salvatore Privitera J.D. owns shares in one company:

Company Title Shares Price per share Total value
AtriCure, Inc. (ATRC) Chief Technical Officer 103,290 $35.5 $3,666,795

What does AtriCure, Inc. do?

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Salvatore Privitera J.D. insider trading

AtriCure, Inc.

Mr. Salvatore Privitera J.D. has made 11 insider trades between 2009-2024, according to the Form 4 filled with the SEC. Most recently he purchased 5,000 units of ATRC stock worth $111,250 on 30 May 2024.

The largest trade he's ever made was exercising 10,654 units of ATRC stock on 17 Dec 2020. As of 30 May 2024 he still owns at least 103,290 units of ATRC stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $22.25 $111,250
Sale
Common Stock 8,808 $85 $748,680
Sale
Common Stock 8,000 $82.5 $660,000
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 10,654 $51.33 $546,870
Sale
Common Stock 3,846 $47.5 $182,685
Sale
Common Stock 5,590 $13.45 $75,186
Sale
Common Stock 3,360 $14.29 $48,014
Sale
Common Stock 5,000 $5.25 $26,250
Sale
Common Stock 5,000 $3.75 $18,750
Sale
Common Stock 5,000 $3.25 $16,250
Sale
Common Stock 5,000 $3.25 $16,250

AtriCure key executives

AtriCure, Inc. executives and other stock owners filed with the SEC: